Health Results Based Financing Impact Evaluation 2018, Household Follow-up (Endline) Survey
Tajikistan, 2018
Get Microdata
Reference ID
TJK_2018_HRBFIE-HEL_v01_M
Producer(s)
Gil Shapira, Damien de Walque
Collection(s)
Metadata
Created on
Nov 12, 2019
Last modified
Nov 12, 2019
Page views
53796
Downloads
491
s20q16_other: What (else) was given to treat the diarrhea? - Other (s20q16_other)
Data file: hh_s20
Overview
Valid:
131
Invalid:
0
Type:
Discrete
Start:
79
End:
119
Width:
41
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| amaksatsilin | 1 |
0.8%
|
|
| amkasadin | 1 |
0.8%
|
|
| amoksatsilin | 1 |
0.8%
|
|
| baktoks suspenziÿ | 1 |
0.8%
|
|
| bifidobakterin parashok | 1 |
0.8%
|
|
| bifidum | 1 |
0.8%
|
|
| bifidum bakterin | 1 |
0.8%
|
|
| bifidum bakterium ,laktobakterium, lineks | 1 |
0.8%
|
|
| bifidumbakter | 1 |
0.8%
|
|
| bifidumbakterin | 2 |
1.5%
|
|
| bifudim bakteriÿ | 1 |
0.8%
|
|
| doru | 1 |
0.8%
|
|
| doruho az alaf tayer shuda | 1 |
0.8%
|
|
| drotovarin | 1 |
0.8%
|
|
| furazalidol | 1 |
0.8%
|
|
| furazalidol paratsitamol | 1 |
0.8%
|
|
| furazalidon | 20 |
15.3%
|
|
| furazalidonn | 1 |
0.8%
|
|
| furazolidon | 15 |
11.5%
|
|
| furazolidon imodiþm | 1 |
0.8%
|
|
| furozalidon | 1 |
0.8%
|
|
| furozolidon | 1 |
0.8%
|
|
| imodium | 4 |
3.1%
|
|
| imodium tetrayiklin | 1 |
0.8%
|
|
| imodiþm | 1 |
0.8%
|
|
| imulab furazalidon | 1 |
0.8%
|
|
| imunal sirop | 1 |
0.8%
|
|
| infab | 2 |
1.5%
|
|
| infab pardifenkids abvgdeyka | 1 |
0.8%
|
|
| istifoda naburdem | 1 |
0.8%
|
|
| kalütsip sirop | 1 |
0.8%
|
|
| laktachi | 1 |
0.8%
|
|
| laktobaktrin | 1 |
0.8%
|
|
| leneks | 1 |
0.8%
|
|
| leniks | 1 |
0.8%
|
|
| levomitsitin | 1 |
0.8%
|
|
| lineks | 8 |
6.1%
|
|
| lineks bifodium bakerium laktobakterium | 1 |
0.8%
|
|
| lineks kapsula | 1 |
0.8%
|
|
| lineks malish | 1 |
0.8%
|
|
| loperamid | 4 |
3.1%
|
|
| nadodaasü | 1 |
0.8%
|
|
| nigram | 1 |
0.8%
|
|
| nurofen | 1 |
0.8%
|
|
| pankreatin lineks | 1 |
0.8%
|
|
| paratsetamol | 2 |
1.5%
|
|
| paratsitamol yovromisidin | 1 |
0.8%
|
|
| polevirit | 1 |
0.8%
|
|
| radium | 2 |
1.5%
|
|
| regidron | 1 |
0.8%
|
|
| ringer | 1 |
0.8%
|
|
| simekta | 1 |
0.8%
|
|
| sipro | 1 |
0.8%
|
|
| sipron | 1 |
0.8%
|
|
| sirop | 1 |
0.8%
|
|
| sirop meridon | 1 |
0.8%
|
|
| sirop optiprim | 1 |
0.8%
|
|
| stopkalip | 1 |
0.8%
|
|
| tedratsiklin | 1 |
0.8%
|
|
| tetratsiklin | 4 |
3.1%
|
|
| tetratsiklin. furazolidon | 1 |
0.8%
|
|
| tetratskilin | 1 |
0.8%
|
|
| tetrptsikilin | 1 |
0.8%
|
|
| tsefrofloksattsin | 1 |
0.8%
|
|
| tseftriakson | 1 |
0.8%
|
|
| tsifralet-250 | 1 |
0.8%
|
|
| tsiproflaksina | 1 |
0.8%
|
|
| tsipron | 1 |
0.8%
|
|
| yomelgey | 1 |
0.8%
|
|
| yomigel | 3 |
2.3%
|
|
| yomigel f | 1 |
0.8%
|
|
| yomigil | 2 |
1.5%
|
|
| yomodium | 1 |
0.8%
|
|
| yospumizan | 1 |
0.8%
|
|
| ÿgon doru doda nashkdast | 1 |
0.8%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.